Hem › Diffust storcelligt B-cellslymfom › Florida
Kliniska studier för Diffust storcelligt B-cellslymfom i Florida
23 studier för Diffust storcelligt B-cellslymfom söker deltagare vid platser i Florida.
Städer i Florida
Officiell studietext (engelska)
Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL
- Miami Cancer Institute at Baptist Health, Inc., Miami
- Advent Health Cancer Institute, Orlando
- Orlando Health Cancer Institute, Orlando
- och 1 fler
RekryterarFas 2
Ålder 18 och äldre · Alla kön · Uppdaterad 2 okt. 2026 · NCT06500273Golcadomide and Rituximab as Bridging Therapy for Relapsed or Refractory Aggressive B-cell Non-Hodgkin Lymphoma Before CAR T-cell Therapy
- Mayo Clinic in Florida, Jacksonville
RekryterarFas 2
Ålder 18 och äldre · Alla kön · Uppdaterad 2 okt. 2026 · NCT06834373A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies
- Mayo Clinic Jacksonville, Jacksonville
- Mount Sinai Medical Center Braman Comprehensive Cancer Center, Miami
- Tampa General Hospital Cancer Institute, Tampa
RekryterarFas 1/2
Ålder 18 och äldre · Alla kön · Uppdaterad 28 sep. 2026 · NCT05006716A Study to Evaluate Zilovertamab Vedotin (MK-2140) Combination With Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone (R-CHOP) in Participants With Previously Untreated DLBCL (MK-2140-010)
- Clermont Oncology Center ( Site 0182), Clermont
- Bioresearch Partner ( Site 0157), Hialeah
- Orlando Health Cancer Institute ( Site 0169), Ocoee
- och 1 fler
RekryterarFas 3
Ålder 18 och äldre · Alla kön · Uppdaterad 25 sep. 2026 · NCT06717347A Study to Compare How Well Odronextamab Combined With Chemotherapy Works and How Safe it is Against Rituximab Combined With Chemotherapy, in Adult Patients With Previously Untreated Diffuse Large B-cell Lymphoma
- Mayo Clinic Jacksonville, Jacksonville
RekryterarFas 3
Ålder 18 och äldre · Alla kön · Uppdaterad 25 sep. 2026 · NCT06091865A Study of Zilovertamab Vedotin (MK-2140) in Combination With Standard of Care in Participants With Relapsed or Refractory Diffuse Large B-Cell Lymphoma (rrDLBCL) (MK-2140-003)
- Boca Raton Regional Hospital- Lynn Cancer Institute ( Site 0163), Boca Raton
- Clermont Oncology Center ( Site 0174), Clermont
- BRP-Hialeah Hospital ( Site 0182), Hialeah
RekryterarFas 2/3
Ålder 18 och äldre · Alla kön · Uppdaterad 25 sep. 2026 · NCT05139017A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)
- Boca Raton Regional Hospital-Lynn Cancer Institute ( Site 0130), Boca Raton
- Baptist MD Anderson Cancer Center ( Site 0176), Jacksonville
- Mount Sinai Braman Comprehensive Cancer Center ( Site 0140), Miami Beach
- och 1 fler
RekryterarFas 2
Ålder 18 och äldre · Alla kön · Uppdaterad 25 sep. 2026 · NCT06890884A Study of LY4584180 in Adult Participants With Previously Treated Blood Cancers
- University of Miami - Sylvester Cancer Center, Miami
- Florida Cancer Specialists - Sarasota, Sarasota
RekryterarFas 1
Ålder 18 och äldre · Alla kön · Uppdaterad 22 sep. 2026 · NCT07226843Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)
- Johns Hopkins All Children's Hospital ( Site 1025), St. Petersburg
RekryterarFas 1/2
6 Months – 25 Years · Alla kön · Uppdaterad 17 sep. 2026 · NCT06395103Itacitinib Pre-modulation in DLBCL Receiving CAR T Cell Therapy
- Moffitt Cancer Center, Tampa
RekryterarFas 2
Ålder 18 och äldre · Alla kön · Uppdaterad 16 sep. 2026 · NCT05757219Evaluate Optimization of CRS Profile for Glofit Monotherapy and Glofit+GemOx in R/R Aggressive B-NHL
- North Florida/ South Georgia VA Medical Center, Gainesville
- Mount Sinai Comprehensive Cancer Center, Miami
- Orlando Health Cancer Institute, Orlando
RekryterarFas 2
Ålder 18 och äldre · Alla kön · Uppdaterad 11 sep. 2026 · NCT06806033Gene Therapy for CD19-Positive Hematologic Malignancies (SENTRY-CD19)
- Mayo Clinic, Clinical Trials Referral Office, Jacksonville
RekryterarFas 1/2
Ålder 13 till 90 · Alla kön · Uppdaterad 6 aug. 2026 · NCT06533579A Study to Investigate Ronde-cel Versus Investigator's Choice CD19 CAR T-Cell Therapy
- Mayo Clinic Florida, Jacksonville
- AdventHealth, Orlando
- Moffitt Cancer Center, Tampa
RekryterarFas 3
Ålder 18 och äldre · Alla kön · Uppdaterad 4 aug. 2026 · NCT07188558A Study of APG-3288 in Relapsed/Refractory Blood Cancers
- Mayo Clinic, Jacksonville
RekryterarFas 1
Ålder 18 och äldre · Alla kön · Uppdaterad 30 juli 2026 · NCT07424833DALY II USA/ MB-CART2019.1 for DLBCL
- Baptist Health Miami Cancer Institute, Miami
RekryterarFas 2
Ålder 18 och äldre · Alla kön · Uppdaterad 13 juli 2026 · NCT04792489Testing the Combination of Anti-cancer Drugs Mosunetuzumab, Polatuzumab Vedotin, and Lenalidomide for the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma
- Moffitt Cancer Center, Tampa
RekryterarFas 1
Ålder 18 och äldre · Alla kön · Uppdaterad 9 juli 2026 · NCT06015880A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies
- University of Miami, Miami
- Florida Cancer Specialists, Sarasota
RekryterarFas 1
Ålder 18 och äldre · Alla kön · Uppdaterad 2 juli 2026 · NCT05131022The OPAL Study: AVM0703 for Treatment of Lymphoid Malignancies
- ASCLEPES Research Centers, Weeki Wachee
RekryterarFas 1/2
Ålder 12 till 95 · Alla kön · Uppdaterad 15 apr. 2026 · NCT04329728A Phase II Study of Glofitamab Plus Polatuzumab-R-CHP for Patients With High-risk Diffuse Large B-cell Lymphoma
- University of Miami Sylvester Cancer Center, Miami
RekryterarFas 2
Ålder 18 och äldre · Alla kön · Uppdaterad 5 mars 2026 · NCT05800366B-Cell Activating Factor Receptor (BAFFR)-Based Chimeric Antigen Receptor T-Cells With Fludarabine and Cyclophosphamide Lymphodepletion for the Treatment of Relapsed or Refractory B-cell Hematologic Malignancies
- Mayo Clinic in Florida, Jacksonville
RekryterarFas 1
Ålder 18 och äldre · Alla kön · Uppdaterad 13 feb. 2026 · NCT06191887Testing Drug Treatments After CAR T-cell Therapy in Patients With Relapsed/Refractory Diffuse Large B-cell Lymphoma
- UF Health Cancer Institute - Gainesville, Gainesville
RekryterarFas 2
Ålder 18 och äldre · Alla kön · Uppdaterad 2 feb. 2026 · NCT05633615Study Adding Drugs to Usual Treatment for Large B-Cell Lymphoma That Returned or Did Not Respond to Treatment
- Holy Cross Hospital, Fort Lauderdale
RekryterarFas 2
Ålder 18 och äldre · Alla kön · Uppdaterad 20 okt. 2025 · NCT05890352A Study of AC676 for the Treatment of Relapsed/Refractory B-Cell Malignancies
- Florida Cancer Specialists, Sarasota
RekryterarFas 1
Ålder 18 och äldre · Alla kön · Uppdaterad 2 okt. 2025 · NCT05780034Från ClinicalTrials.gov, data hämtad 3 okt. 2026. Varje studie har egna kvalifikationskrav; studieteamet avgör vem som kan delta.